J&J | Built to matter: oncology startup strategies to stand out in a crowded market

J&J | Built to matter: oncology startup strategies to stand out in a crowded market

This Johnson & Johnson Innovation event brings together investors, pharma leaders, biotech executives and advisors to explore the strategic choices that can make oncology startups more investable, partnerable and attractive to potential acquirers.

Gain practical perspectives on the strategic decisions that can shape an oncology venture’s path forward. The programme will explore investor and buyer expectations, clinical development considerations and the factors that influence successful partnerships.

Register for the event here.

Testimonials

testimonial

Most relevant, interesting and practical training I have ever had, very interactive an multi-disciplinary. It makes an IMPACT.

Edith van Lishout

KU Leuven, Belgium

testimonial

Was great to meet counterparts in my profession who may share my experiences, but who may also have other ideas and approaches.

Tim Moser

Netherlands Cancer Institute, Netherlands

testimonial

Always simply inspiring! That is ASTP.

Filip Auinger

Palacký University Olomouc, Czech Republic

testimonial

Technology transfer is ever changing and a key piece for the competitiveness of your institution, this course is an excellent tool to prepare yourself for that challenge.

Ricardo Castro

Centre for research in agricultural Genomics, Spain

testimonial

Working and Learning with old and new friends – best way to do it!

Sara Matt-Leubner

University of Innsbruck, Austria